Clinical Trial: Phase II Study of THDBH120 Injection in Overweight or Obese Subjects

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07036601) titled 'Phase II Study of THDBH120 Injection in Overweight or Obese Subjects' on June 16.

Brief Summary: To assess the efficacy and safety of THDBH120 injection compared with placebo in weight reduction in overweight or obese subjects after 26 weeks of treatment.

Study Start Date: Jan. 06

Study Type: INTERVENTIONAL

Condition: Overweight or Obese

Intervention: DRUG: THDBH120 injection

Participants received THDBH120 by subcutaneous injection.

DRUG: Placebo of THDBH120 injection

Participants received placebo by subcutaneous injection.

Recruitment Status: RECRUITING

Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd

Disclaimer: Curated...